Rezaei Kalantari H
Oncologue, CH. Peltzer La Tourelle, Velviers, Belgique.
Rev Med Liege. 2010 Sep;65(9):490-2.
I report two cases of malignant peritoneal mesothelioma. Mesothelioma is mostly a pleural disease whether visceral or parietal. Infra-diaphragmatic Mesothelioma accounts for only 10-20% of all mesotheliomas. In over 80% of the cases the pathogenesis is related to asbestos and radiation exposure. However cases with no past history of such exposures appear in the literature. One of our two patients has non past history of exposure to asbestos. In both cases the diagnosis was establishes through both biopsy conducted by laparoscopy and ascites fluid cytology. The disease is most common in males over the age of 40. In case of localised disease cytoreductive surgery using hyperthermic intraperitoneal chemotherapy is recommended. Sadly the disease is often unveiled at an advanced stage requiring palliative chemotherapy usually with a platin derivative or in a small percentage of the cases with abdominal radiotherapy to alleviate pain. Prognosis for patients with malignant peritoneal mesothelioma is very poor with a mean survival of 5,4 months versus 12.5 months for pleural mesothelioma. Peritoneal mesothelioma, although rare, should be considered among the differential diagnosis of ascites differential diagnosis work up.
我报告了两例恶性腹膜间皮瘤病例。间皮瘤大多是一种胸膜疾病,无论是脏层还是壁层。膈下间皮瘤仅占所有间皮瘤的10%-20%。超过80%的病例发病机制与石棉和辐射暴露有关。然而,文献中也出现了无此类暴露既往史的病例。我们的两名患者中有一名无石棉暴露既往史。在这两个病例中,诊断都是通过腹腔镜活检和腹水细胞学检查确定的。这种疾病在40岁以上男性中最为常见。对于局限性疾病,建议采用腹腔内热灌注化疗进行细胞减灭术。遗憾的是,这种疾病往往在晚期才被发现,通常需要使用铂类衍生物进行姑息化疗,或在少数情况下进行腹部放疗以缓解疼痛。恶性腹膜间皮瘤患者的预后非常差,平均生存期为5.4个月,而胸膜间皮瘤患者为12.5个月。腹膜间皮瘤虽然罕见,但在腹水鉴别诊断检查的鉴别诊断中应予以考虑。